XML 33 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock-Based Compensation (Tables)
9 Months Ended
Nov. 03, 2018
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Valuation Assumptions for Stock Options

The fair value of each option granted is estimated on the date of grant using the Black-Scholes option-pricing model.  The following assumptions were used for grants for the first nine months of fiscal 2018 and fiscal 2017, respectively:

 

 

 

For the nine months ended

 

 

 

November 3, 2018

 

October 28, 2017

 

Expected volatility

 

48.9% - 57.1%

 

 

49.9

%

Risk-free interest rate

 

2.55% - 2.63%

 

1.44%

 

Expected life

 

3.0 - 4.5 yrs.

 

3.0 yrs

 

Dividend rate

 

-

 

 

 

Employee Stock Plan, 2006 Plan and 2016 Plan  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of Restricted Stock Activity

The following tables summarize the share activity and stock option activity for the Company’s 2006 Plan and 2016 Plan, on a combined basis, for the first nine months of fiscal 2018:

 

 

 

Restricted shares

 

 

Restricted stock units (1)

 

 

Deferred shares (2)

 

 

Fully-vested

shares (3)

 

 

Total number of shares

 

 

Weighted-average

grant-date

fair value (4)

 

Shares

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding non-vested shares at beginning of year

 

 

36,666

 

 

 

1,048,552

 

 

 

115,457

 

 

 

 

 

 

1,200,675

 

 

$

3.43

 

Shares granted

 

 

30,000

 

 

 

1,050,650

 

 

 

82,289

 

 

 

105,645

 

 

 

1,268,584

 

 

$

2.48

 

Shares vested/issued

 

 

(3,333

)

 

 

(627,220

)

 

 

(7,708

)

 

 

(105,645

)

 

 

(743,906

)

 

$

2.98

 

Shares canceled

 

 

(33,333

)

 

 

(91,747

)

 

 

 

 

 

 

 

 

(125,080

)

 

$

2.84

 

Outstanding non-vested shares at end of quarter

 

 

30,000

 

 

 

1,380,235

 

 

 

190,038

 

 

 

 

 

 

1,600,273

 

 

$

2.93

 

 

 

(1)

RSUs were primarily granted in connection with the partial achievement of performance targets under the 2016-2017 LTIP and time-based awards under the 2018-2020 LTIP, see Note 4, Long-Term Incentive Plans. As a result of net share settlement, of the 627,220 RSUs which vested during the first nine months of fiscal 2018, only 573,094 shares of common stock were issued.  

 

(2)

The 82,289 shares of deferred stock, with a fair value of $162,984, represent compensation to certain directors in lieu of cash, in accordance with their irrevocable elections.  The shares of deferred stock will vest three years from the date of grant or at separation of service, based on the irrevocable election of each director.

 

(3)

During the first nine months of fiscal 2018, the Company granted 105,645 shares of stock, with a fair value of approximately $204,475, to certain directors as compensation in lieu of cash, in accordance with their irrevocable elections. Directors are required to elect 50% of their quarterly retainer in equity.  Any shares in excess of the minimum required election are issued from the Company’s Third Amended and Restated Non-Employee Director Compensation Plan (“Non-Employee Director Compensation Plan”).

 

(4)

The fair value of a restricted share, deferred share and fully-vested share is equal to the Company’s closing stock price on the day immediately preceding the date of grant.

Stock Option Activity

 

 

 

Number of

shares

 

 

Weighted-average

exercise price

per option

 

 

Weighted-average

remaining

contractual term

 

Aggregate

intrinsic value

 

Stock Options

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding options at beginning of year

 

 

1,195,910

 

 

$

4.80

 

 

 

 

$

21,750

 

Options granted

 

 

153,888

 

 

$

2.48

 

 

 

 

 

 

Options expired and canceled

 

 

(366,626

)

 

$

4.73

 

 

 

 

 

2,000

 

Options exercised

 

 

 

 

 

 

 

 

 

 

 

Outstanding options at end of quarter

 

 

983,172

 

 

$

4.49

 

 

5.1 years

 

$

144,396

 

Options exercisable at end of quarter

 

 

829,284

 

 

$

4.87

 

 

4.3 years

 

$

26,308